ACXP

Acurx Pharmaceuticals, Inc. ACXP

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ACXP BCLI VYNE NRSN QNNTF SNGX IBO AIM EPIX RASP
6M 8.28 % -10.81 % -76.21 % 14.15 % 0.00 % -21.43 % 21.31 % -14.18 % -87.27 % -90.00 %
YTD -54.30 % -68.22 % -88.86 % 5.22 % 0.00 % -42.01 % -61.00 % -88.30 % -89.01 % -90.00 %
1Y -81.27 % -68.95 % -81.54 % 11.01 % 0.00 % -51.56 % -51.95 % -90.10 % -96.66 % -90.00 %
3Y -87.81 % -98.72 % -91.41 % -32.40 % -97.06 % -98.72 % -99.85 % -94.64 % -89.94 % -96.69 %
5Y -95.13 % -99.73 % -99.73 % -70.05 % -98.20 % -99.60 % -99.85 % -98.91 % -96.89 % -99.50 %
10Y -95.13 % -98.34 % -99.98 % -70.05 % -98.20 % -99.93 % -97.60 % -99.97 % -99.85 % -99.91 %
From the beginning -95.13 % -73.12 % -99.98 % -70.05 % -98.20 % -100.00 % -97.60 % -71.92 % -99.77 % -99.94 %

Dividend

ESSA Pharma Inc.